Form 4: Viatris Inc. Director W. Don Cornwell Reports Stock Transactions

Director W. Don Cornwell reports the vesting and conversion of restricted stock units and dividend equivalent units into Viatris Inc. common stock.

Summary

• On March 3, 2024, W. Don Cornwell, a director of Viatris Inc., engaged in transactions involving restricted stock units (RSUs) and dividend equivalent units (DEUs).
• 17,970 RSUs vested and were converted into common stock at a price of $0.00.
• Additionally, 885 fractional shares were acquired due to the settlement of RSUs.
• Cornwell also acquired 884.8005 DEUs that vested on the same schedule as the underlying RSUs.
• On March 4, 2024, Cornwell acquired 18,204 RSUs that will vest on March 4, 2025.
• Following these transactions, Cornwell directly owns 61,365 shares of Viatris Inc. common stock and 18,204 RSUs.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of insider transactions. It doesn't contain information that would significantly impact sentiment positively or negatively.

Positives

• The vesting of RSUs and DEUs indicates that performance milestones were likely met, which is generally a positive sign.

Future Outlook

The document indicates future vesting of RSUs on March 4, 2025, suggesting continued equity-based compensation for the director.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in company stock. This filing indicates ongoing equity compensation practices at Viatris Inc.

Comparison to Industry Standards

• Equity compensation through RSUs is a common practice among publicly traded companies to align the interests of directors and executives with those of shareholders.
• The vesting schedules and terms of the RSUs are likely comparable to those offered by peer companies in the pharmaceutical industry.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect standard equity compensation practices.

Key Dates